Paper41501059
Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases.
Kong F and 8 others. Nat Commun, 2026. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases. Papers, record 41501059. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41501059
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucagon-Like Peptide-1 Receptor Agonists | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Hypoglycemic Agents | Major topic |
| Humans | |
| Treatment Outcome | |
| Meta-Analysis as Topic | |
| Glucagon-Like Peptide-1 Receptor |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36396031 | Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction. | Mol Metab | 2022 | https://conductscience.org/library/papers/36396031 | PubMed |
| 2 | 36620987 | Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease. | Lancet Gastroenterol Hepatol | 2023 | https://conductscience.org/library/papers/36620987 | PubMed |
| 3 | 17928588 | The physiology of glucagon-like peptide 1. | Physiol Rev | 2007 | https://conductscience.org/library/papers/17928588 | PubMed |
| 4 | 38542021 | Novel Antidiabetic Drugs and the Risk of Diabetic Retinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | J Clin Med | 2024 | https://conductscience.org/library/papers/38542021 | PubMed |
| 5 | 28538729 | Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein. | Nature | 2017 | https://conductscience.org/library/papers/28538729 | PubMed |
| 6 | 37796527 | Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. | JAMA | 2023 | https://conductscience.org/library/papers/37796527 | PubMed |
| 7 | 31195981 | miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. | Mol Med | 2019 | https://conductscience.org/library/papers/31195981 | PubMed |
| 8 | 21195583 | GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. | J Clin Epidemiol | 2011 | https://conductscience.org/library/papers/21195583 | PubMed |
| 9 | 39089293 | Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial. | Lancet Diabetes Endocrinol | 2024 | https://conductscience.org/library/papers/39089293 | PubMed |
| 10 | 30728472 | Antibodies and venom peptides: new modalities for ion channels. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30728472 | PubMed |
| 11 | 38031234 | Incretin-based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta-analysis of observational studies. | Diabetes Obes Metab | 2024 | https://conductscience.org/library/papers/38031234 | PubMed |
| 12 | 36203933 | The AMPK pathway in fatty liver disease. | Front Physiol | 2022 | https://conductscience.org/library/papers/36203933 | PubMed |
| 13 | 24599780 | The impact of peri-operative anti-TNF treatment on anastomosis-related complications in Crohn's disease patients. A critical review. | J Gastrointest Surg | 2014 | https://conductscience.org/library/papers/24599780 | PubMed |
| 14 | 39813121 | GLP-1 and the Neurobiology of Eating Control: Recent Advances. | Endocrinology | 2025 | https://conductscience.org/library/papers/39813121 | PubMed |
| 15 | 37019448 | Dietary sugar consumption and health: umbrella review. | BMJ | 2023 | https://conductscience.org/library/papers/37019448 | PubMed |
| 16 | 21148304 | Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. | Clin Chem | 2011 | https://conductscience.org/library/papers/21148304 | PubMed |
| 17 | 40105856 | Suicide and Self-Harm Events With GLP-1 Receptor Agonists in Adults With Diabetes or Obesity: A Systematic Review and Meta-Analysis. | JAMA Psychiatry | 2025 | https://conductscience.org/library/papers/40105856 | PubMed |
| 18 | 25475437 | PKA Enhances the Acute Insulin Response Leading to the Restoration of Glucose Control. | Diabetes | 2015 | https://conductscience.org/library/papers/25475437 | PubMed |
| 19 | 37993201 | Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction. | J Am Coll Cardiol | 2023 | https://conductscience.org/library/papers/37993201 | PubMed |
| 20 | 39438043 | Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study. | BMJ | 2024 | https://conductscience.org/library/papers/39438043 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909776 | Lessons from dog lifespan therapeutics for their human companions. | Geroscience | 2026 | https://conductscience.org/library/papers/42909776 | PubMed |
| 42889249 | Modern Obesity Treatment: Efficacy, Safety, and Future Directions of GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) Receptor Agonists. | Cureus | 2026 | https://conductscience.org/library/papers/42889249 | PubMed |
| 42738922 | Lifestyle Medicine as Co-Therapy During Incretin-Based Anti-Obesity Pharmacotherapy: Integrating Physical Activity, Nutrition, and Behavioral Strategies for Long-Term Success. | Nutrients | 2026 | https://conductscience.org/library/papers/42738922 | PubMed |
| 42712076 | A Biweekly GLP-1R Agonist Designed With Drug-Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42712076 | PubMed |
| 42683789 | Are Glucagon-Like Peptide-1 Receptor Agonists Suitable for Secondary Stroke Prevention? | J Clin Neurol | 2026 | https://conductscience.org/library/papers/42683789 | PubMed |
| 42668762 | Multisystem Benefits of GLP-1 Microdosing: A Narrative Review. | Cureus | 2026 | https://conductscience.org/library/papers/42668762 | PubMed |
| 42601733 | A cross-sectional survey on exploring adherence to diabetes treatment regimens: Insights from Hail region, Saudi Arabia. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42601733 | PubMed |
| 42511630 | Psyllium and Glucomannan as Viscous Fiber Modulators of the Gut-Microbiome-Incretin Axis: Molecular Links to Metabolic Inflammation, Barrier Function, and GLP-1 Receptor Agonist Therapy. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511630 | PubMed |
| 42457963 | Food systems transformation would reshape global agriculture. | Nature | 2026 | https://conductscience.org/library/papers/42457963 | PubMed |
| 42451115 | Dual Activation of GLP-1 and AMPK Pathways by a Multi-Botanical Formulation Improves Obesity and Metabolic Dysfunction in Experimental Models. | Nutrients | 2026 | https://conductscience.org/library/papers/42451115 | PubMed |
| 42380553 | GLP-1-Based Therapies in Type 1 Diabetes: Emerging Evidence on Cardiovascular, Renal, and Safety Outcomes. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42380553 | PubMed |
| 42280404 | Adherence and Persistence with GLP-1-Based Therapies: International Real-World Evidence and the Role of Nutritional and Lifestyle Support-A Narrative Review. | Nutrients | 2026 | https://conductscience.org/library/papers/42280404 | PubMed |
| 42249138 | Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial. | Nat Med | 2026 | https://conductscience.org/library/papers/42249138 | PubMed |
| 42201157 | Beyond Glycemic Control: Ocular Effects of Glucagon-like Peptide-1 Receptor Agonists. | Vision (Basel) | 2026 | https://conductscience.org/library/papers/42201157 | PubMed |
| 42198298 | GLP-1 Receptor Agonists in Chronic Inflammatory Skin Diseases: Immunometabolic Mechanisms and Translational Perspectives. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42198298 | PubMed |
| 42131480 | GLP-1 receptor and Mitochondria-ER Contact Sites: an emerging mechanism of metabolic regulation. | Front Physiol | 2026 | https://conductscience.org/library/papers/42131480 | PubMed |
| 42074711 | Effects of GLP-1 Agonists on Patients with Hidradenitis Suppurativa: A Systematic Review. | J Clin Med | 2026 | https://conductscience.org/library/papers/42074711 | PubMed |
| 41786648 | Response to the Letter to the Editor on "Perioperative GLP-1 Receptor Agonist Use is Associated with Reduced Revisions and Complications Following ACDF: A Propensity-Matched Analysis". | Global Spine J | 2026 | https://conductscience.org/library/papers/41786648 | PubMed |
| 41683830 | Orforglipron: A Comprehensive Review of an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity and Type 2 Diabetes. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683830 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41501059
GET https://conductscience.org/api/papers/v1/41501059/references?page=2